KENNETH RAINEY: Open Payments
NPI 1801544184 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $4 · 2025 $466
Food & beverage: $461Education: $6
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $86 |
| Travere Therapeutics, Inc. | 3 | $6 |
Products named: TARPEYO, XPHOZAH 30 MG, Ozempic, Filspari.
Industry payments across TN — which companies pay providers there.
